165 related articles for article (PubMed ID: 36908718)
21. Secondary parenchymal CNS involvement by lymphoma including rare types: Follicular and EBV-positive NK/T cell lymphoma, nasal type.
Kleinschmidt-DeMasters BK; Gilani A
Ann Diagn Pathol; 2021 Aug; 53():151765. PubMed ID: 34147846
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
Suzuki R
Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
[TBL] [Abstract][Full Text] [Related]
24. Extranodal NK/T-cell lymphoma, nasal type (angiocentric T-cell lymphoma): A review about the terminology.
Metgud RS; Doshi JJ; Gaurkhede S; Dongre R; Karle R
J Oral Maxillofac Pathol; 2011 Jan; 15(1):96-100. PubMed ID: 21731288
[TBL] [Abstract][Full Text] [Related]
25. Extranodal NK/T-cell lymphoma: Updates in biology and management strategies.
Yamaguchi M; Oguchi M; Suzuki R
Best Pract Res Clin Haematol; 2018 Sep; 31(3):315-321. PubMed ID: 30213402
[TBL] [Abstract][Full Text] [Related]
26. Extranodal natural killer/T-cell lymphoma nasal type.
Daines BS; Varman RM; Nguyen TQ
Proc (Bayl Univ Med Cent); 2022; 35(5):672-674. PubMed ID: 35991731
[TBL] [Abstract][Full Text] [Related]
27. MRI appearances of stage IE/IIE extranodal NK/T-cell lymphoma, nasal type, in the upper aerodigestive tract.
Gu Y; Wu B; Zhang Y; Guo Y; Peng W
Eur Rev Med Pharmacol Sci; 2014; 18(3):404-12. PubMed ID: 24563442
[TBL] [Abstract][Full Text] [Related]
28. Primary Non-Hodgkin's Lymphoma of the Nose: A Rare Case Report.
Biradar K; Bishnoi T; Sahu PK; Paramasivam PK
Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):1069-1071. PubMed ID: 37206787
[TBL] [Abstract][Full Text] [Related]
29. [Clinical Characteristics and Prognostic Analysis of Extranodal NK/T-Cell Lymphoma Patients Treated with Pegaspargase Based Chemotherapy].
Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):735-740. PubMed ID: 34105466
[TBL] [Abstract][Full Text] [Related]
30. Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses.
Nikolaos N; Grigorios P; Konstantinos K; Savvas T; Vassiliki Z; Alexandra S; Theodoros P
Am J Case Rep; 2012; 13():79-85. PubMed ID: 23569495
[TBL] [Abstract][Full Text] [Related]
31. NK/T Cell Lymphoma: Updates in Therapy.
Suzuki R
Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
[TBL] [Abstract][Full Text] [Related]
32. Serum ferritin level is prognostic of patient outcome in extranodal NK/T cell lymphoma, nasal type.
Yamazaki E; Tomita N; Koyama S; Ogusa E; Ishii Y; Takahashi H; Miyashita K; Matsuura S; Tachibana T; Takasaki H; Takemura S; Fujimaki K; Sakai R; Fujisawa S; Ishigatsubo Y
Med Oncol; 2014 Sep; 31(9):149. PubMed ID: 25108598
[TBL] [Abstract][Full Text] [Related]
33. [Relapse in the nasal cavity of a patient with extranodal NK/T-cell lymphoma initially presenting as plantar subcutaneous tumor].
Sakaguchi H; Miyazaki K; Tono Y; Fujieda A; Nakamori Y; Mizutani M; Sekine T; Shibazaki T; Oka K; Katou K; Monma F; Yamaguchi M; Masuya M; Katayama N
Rinsho Ketsueki; 2015 Aug; 56(8):1076-81. PubMed ID: 26345570
[TBL] [Abstract][Full Text] [Related]
34. Different clinical characteristics and treatment strategies for patients with localized sinonasal diffuse large B cell lymphoma and extranodal NK/T cell lymphoma.
Huang Y; Jia B; Jiang S; Zhou S; Yang J; Liu P; Gui L; He X; Qin Y; Sun Y; Shi Y
J Hematol Oncol; 2017 Jan; 10(1):7. PubMed ID: 28057019
[TBL] [Abstract][Full Text] [Related]
35. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
Makita S; Tobinai K
Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
[TBL] [Abstract][Full Text] [Related]
36. [The clinical significance of serum Epstein-Barr virus-determined nuclear antigen 1 (EBNA1)/latent membrane protein 1 (LMP1) assay in patients with nasal type extranodal NK/T-cell lymphoma].
Yao N; Cui X; Wang J
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):106-10. PubMed ID: 25907839
[TBL] [Abstract][Full Text] [Related]
37. [Extranodal natural killer/T-cell lymphoma, nasal type developing central nervous system and epididymis involvement immediately after concurrent chemoradiotherapy].
Sasaki Y; Yonezawa A; Kinoshita Y; Kitagawa T; Mori M; Onaka T; Imada K
Rinsho Ketsueki; 2015 Dec; 56(12):2472-6. PubMed ID: 26725358
[TBL] [Abstract][Full Text] [Related]
38. Extranodal natural killer/T cell lymphoma, nasal type: a diagnostic challenge.
Gomes PS; Caselhos S; Vide AT; Fonseca R
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31780623
[TBL] [Abstract][Full Text] [Related]
39. Extranodal NK/T cell lymphoma, nasal type, of the small intestine diagnosed by double-balloon endoscopy.
Wakabayashi S; Arai A; Oshikawa G; Araki A; Watanabe M; Uchida N; Taniguchi S; Miura O
Int J Hematol; 2009 Dec; 90(5):605-610. PubMed ID: 19936878
[TBL] [Abstract][Full Text] [Related]
40. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
